ABVC Biopharma Files 8-K on Operations and Financials
Ticker: ABVC · Form: 8-K · Filed: May 1, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting
TL;DR
ABVC Bio filed an 8-K on May 1st detailing financial condition and results. No specific numbers yet.
AI Summary
ABVC Biopharma, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing serves as an official update from ABVC Biopharma, Inc. to the SEC regarding its financial condition and operational results, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting event and does not contain information indicating immediate or significant risk.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- May 1, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-40700 (identifier) — SEC File Number
- 26-0014658 (identifier) — IRS Employer Identification No.
- 44370 Old Warm Springs Blvd. Fremont, CA 94538 (address) — Principal executive office address
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not include specific financial figures or operational details.
When was this 8-K filing submitted by ABVC Biopharma, Inc.?
The filing was made as of May 1, 2025, with the date of the earliest event reported also being May 1, 2025.
What is the state of incorporation for ABVC Biopharma, Inc.?
ABVC Biopharma, Inc. is incorporated in Nevada.
What is the SEC file number for ABVC Biopharma, Inc.?
The SEC file number for ABVC Biopharma, Inc. is 001-40700.
Where are ABVC Biopharma, Inc.'s principal executive offices located?
The principal executive offices of ABVC Biopharma, Inc. are located at 44370 Old Warm Springs Blvd., Fremont, CA 94538.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).